Short description:
SLC transporter Drug Discovery
Drug notes:
5+ additional undisclosed programs RD immune-mediated & inflammatory diseases, oncology, neurology
Long description:
Jnana Therapeutics is creating therapies to treat a wide variety of diseases by uncovering and targeting unique binding sites of highly validated protein targets. Chemoproteomics is facilitating drug discovery for previously inaccessible protein targets. Jnana has built a next-generation chemoproteomics platform, RAPID, to develop small molecule medicines for any target with unprecedented speed and efficiency. This approach is enabling Jnana to address a range of challenging target classes including SLC transporters, transcription factors and signaling scaffold proteins that are significant drivers of disease. Their lead candidate, JNT-517, is targeting a SLC transporter that plays a role in PKU.
Jobs:
Global Head of Project Management Hybrid - US|14 days ago
Director/Senior Director, Head of Medical Affairs Hybrid - US|18 days ago
Director/Senior Director, Clinical Development Hybrid - US|18 days ago
VP/SVP, Head of Clinical Development Hybrid - US|18 days ago
Don't see a perfect job? Apply opportunistically. Boston, Massachusetts, United States|100+ days ago